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Liver Graft Induced Donor Specific Unresponsiveness Without Class I 
and/or Class II Antigen Differences 
S. Qian, H. Sun, AJ. Demetris, F. Fu, T.E. Starzl, and J.J. Fung 
L IVER allografting induces specific systemic unre-
sponsiveness to subsequent other donor tissues in 
pigs. l rats,2 and mice.3..Although the mechanism remains 
unclear, soluble donor crass I major histocompatibility 
complex (MHC) antigens and/or anti-donor class II al-
loantibodies have been proposed as critical components of 
the induced unresponsiveness.2.4.5 If those explanations 
are correct, a liver graft should not be able to protect 
extrahepatic tissues if one or both of these potential 
mechanisms are inoperative. In the present study, the 
induction of unresponsiveness by liver allografts was ob-
served in mouse strain combinations where there was class 
I MHC mismatching only (B lOAKM--+B lOBR, absence of 
anti-donor class II antibodies), class II MHC mismatching 
only EAqe~AqiI absence of class I alloantigens), and 
only minor histocompatibility complex (mHC) mismatch-
ing (B lOBR ~ C3H, absence of both class I and class II 
alloantigens). The results offered a perspective about the 
role of factors other than soluble class I antigens and class 
II antibodies in explaining the mechanisms of liver al-
lograft-induced tolerance. 
MATERIALS AND METHODS 
Animals 
All mice used in this study were purchased from Jackson Labo-
ratory (Bar Harbor, Me) and then kept at the University of 
Pittsburgh Animal Facility until use. Ten to 12-week-old male 
mice were used as donors and recipients in liver, heart, and skin 
transplantation. 
Liver, Heart, and Skin Transplantations 
Orthotopic liver transplantation was performed by Qian's tech-
nique as previously described.6 Heterotopic heart transplantation 
was performed in the abdomen using the method of Corry7 
immediately after liver grafting. Heart graft function was assessed 
daily by palpation. Rejection was defined as the total cessation of 
palpable pulsation, confirmed by autopsy and histologic examina-
tion. 
Skin grafting was completed by placing full thickness tail skin 
grafts (8 mm x 8 mm) on the dorsal ftank of the recipient. Grafts 
were held in place by a gauze dressing and a tape for at least 7 
days. The grafts were assessed daily thereafter. Rejection was 
defined as complete graft destruction. Donor skins were trans-
planted on to the liver recipients more than 100 days following 
acceptance of the hepatic grafts. No immunosuppressive therapy 
was used in this study. 
RESULTS 
Almost all donor skin and heart grafts in liver grafted 
recipients survived more than 100 days (Table I), even 
when no class I MHC alloantigen mismatching (ATH to 
A TL) and no class II MHC alloantigen mismatching 
(B lOAKM to B WBR) were present, or both class I and 
class II alloantigens were mismatched (B lOBR to C3H). 
The heart grafts in B IOAKM to B lOBR combinations were 
spontaneously accepted long term even without prior liver 
grafting (data not shown). 
The results in this study suggest that the donor-specific 
systemic unresponsiveness induced by liver allografting 
may not be due to soluble MHC class I antigens and/or 
MHC class II antibodies, which have long been proposed 
as the components responsible for liver graft-induced 
unresponsiveness. 
From the Departments of Surgery (S.O., H.S., F.F., T.E.S .• 
J.J.F.) and Pathology (A.J.D.), University of Pittsburgh, School of 
Medicine, Pittsburgh, Pennsylvania. 
Address reprint requests to Shiguang Oian, MD. University of 
Pittsburgh, Transplantation Research Laboratory, E1540 Biomed-
ical Science Tower, Pittsburgh, PA 15260. 
© 1993 by Appleton & Lange 
0041-13451931$3.001 +0 
Table 1. Survival of Donor Grafts In Liver Grafted Recipient 
Uver Donor Recipient 
None C3H 
C57BU10 C3H 
None B10BR 
B10AKM B10BR 
None ATl 
ATH ATl 
None C3H 
B10BR C3H 
Disparity 
1,II,mHC 
II 
mHC 
Skin 
15,18,19 
39,>100.>100.>100 
13.13,23.23.23 
Donor Graft SWvIvai (d) 
>100, >100. >100. >100. >100 
14.16,19,19,19 
56: >100, >100 
20.22.22.23 
>100. >100. >100, 100 
Heart 
7, 7, 7, 7, 7 
>100, >100 
9.11,19,22.23 
>100, >100 
13, 13, 13. 13 
>100. >100. >100 
Abbravtations: I. major histocompatibility complex class I: II. major histocompatibility comptex class II . 
• Animal died with living skin graft. 
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LIVER ALLOGRAFT IN MICE 
DISCUSSION 
The immunosuppressive properties of liver grafting have 
b~en intriguing for decades. When the liver is transplanted 
wIth other organs, the additional donor original grafts are 
rejected less vigorously than expected.8 .9 The mechanisms 
remain obscure, although they have been actively investi-
gated. Soluble donor class I antigens released by liver 
graft lO have been considered as main components contrib-
uting to tolerance induction. 
As recently reported in- a 'rat model,4 continuous infu-
sion of donor soluble class I antigen induced a marginal 
prolongation of heart graft survival (from 8.1 ± 0.7 to 10.0 
± 1.5 days), which was amplified by adding the monoclo-
nal anti-class I antibody (15.6 ± 3.0 days). However, the 
results of the present study in the mouse model show that 
liver transplantation is able to induce systemic tolerance. 
in the combinations where the donor and recipient share 
the same MHC class I antigens. Therefore, it, is unlikely 
that allogeneic MHC class I antigen or antibodies exist. 
since the donor and recipient are syngeneic for these 
molecules. 
Anti-donor class II antibodies have been proposed as 
another mechanism of the immunosuppressive effects of 
liver grafting. In the rat model. anti--allo-class II MHC 
antibody titers reached their high levels and were main-
tained for several months after liver grafting:5 However. 
marginal enhancement was achieved by transferring liver 
grafted recipient rat serum IgG from which antibodies to 
class I antigens had been absorbed. Therefore the class II 
antibodies present in liver grafted rat serum were consid-
ered to be the factor responsible for enhancement. II •12 
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However, in our mouse model, liver graft-induced unre-
sponsiveness existed in a system where there was no class 
II disparity, and therefore alloantibodies to class II are 
unlikely to be present. In B lOBR to C3H combination 
donor and recipient shared the same MHC. Despite that 
there were no allogeneic class I antigens and anti-class II 
antibodies in recipient serum, the liver grafts were still able 
to protect both skin and heart grafts. The results of this in 
vivo study suggest that it is inappropriate to overempha-
size the role of class I alloantigens and/or class II MC 
alloantibodies in explanation of liver graft-induced specific 
unresponsiveness. 
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